A new paste to quickly stop bleeding without relying on blood clotting
Hemostatic Bioadhesive Paste for Coagulation-Independent Rapid Control of Bleeding
['FUNDING_SBIR_2'] · SANAHEAL, INC. · NIH-11007752
This study is working on a special paste that helps stop bleeding quickly for patients who take blood thinners or have bleeding disorders, making it safer for them during surgeries.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | SANAHEAL, INC. (nih funded) |
| Locations | 1 site (Somerville, UNITED STATES) |
| Trial ID | NIH-11007752 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a hemostatic bioadhesive paste that can rapidly control bleeding in patients, particularly those who are on anticoagulant medications or have coagulation disorders. The paste works independently of the body's natural blood clotting mechanisms, providing a solution for high-risk bleeding situations during surgeries. The research involves optimizing and validating this paste to meet FDA regulatory standards before moving to clinical trials. The goal is to ensure that this innovative product can be safely and effectively used in medical settings.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients undergoing cardiovascular surgeries or those with bleeding disorders who are at risk of major hemorrhagic events.
Not a fit: Patients who do not have bleeding disorders or are not undergoing procedures that pose a risk of severe bleeding may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new, effective treatment option for patients experiencing severe bleeding, potentially saving lives during critical medical situations.
How similar studies have performed: Previous research has shown promising results with similar hemostatic agents, indicating potential for success with this novel approach.
Where this research is happening
Somerville, UNITED STATES
- SANAHEAL, INC. — Somerville, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: YUK, HYUNWOO — SANAHEAL, INC.
- Study coordinator: YUK, HYUNWOO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Von Willebrand syndrome, Acquired von Willebrand disease